Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Ribavirin slow release nasal gel used for treating cold and preparation method of gel

A technology for gel and nasal use, applied in the field of medicine, can solve the problems of affecting drug absorption and curative effect, reducing patient compliance, short residence time, etc., and achieve the goal of increasing bioavailability, improving bioavailability and long residence time Effect

Inactive Publication Date: 2013-05-08
HUAZHONG UNIV OF SCI & TECH
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The preparation method of nasal drops is simple and the cost is low, but during administration, the loss of nasal drops medicine will cause individual differences, and due to the clearing function of nasal cilia, the retention time of medicinal liquid in the nasal cavity is short, so to a certain extent Affect the absorption and efficacy of the drug
And in the process of many times, nasal drops will inevitably stay in the pharynx, stimulate the pharyngeal mucosa, and symptoms such as dry mouth, dry throat, and sore throat will reduce the patient's compliance

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Ribavirin slow release nasal gel used for treating cold and preparation method of gel
  • Ribavirin slow release nasal gel used for treating cold and preparation method of gel
  • Ribavirin slow release nasal gel used for treating cold and preparation method of gel

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] Embodiment 1 preparation is used for the treatment of the ribavirin sustained-release nasal gel of cold

[0019] Take 5.0g of chitosan, add 900mL of distilled water and 0.1mL of 0.1mol / L hydrochloric acid solution, stir to make it naturally peptized until completely dissolved; then add 5.0g of sodium benzoate and 5.0g of ribavirin, stir well, add distilled water Adjust the total amount to 1000mL, adjust the pH value to 5.8-6.2 with 1.0mol / L sodium hydroxide solution, stir well, and sterilize and dispense.

[0020] Embodiment 2 uses the ribavirin sustained-release nasal gel prepared in embodiment 1 for the treatment of colds to carry out experiments

[0021] 1. In vitro release performance test:

[0022] 1. Purpose of the test:

[0023] Observe the sustained-release effect of the ribavirin sustained-release nasal gel prepared in Example 1 for the treatment of colds.

[0024] 2. Test substance:

[0025] The ribavirin slow-release nasal gel (also known as ribavirin nas...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of pharmacy, and relates to ribavirin slow release nasal gel used for treating cold and flu and a preparation method of the gel. The main components of the ribavirin slow release nasal gel comprise broad-spectrum and strong antiviral ribavirin in effective dose as a main drug and chitosan as the nasal gel matrix. The preparation method comprises the steps of: mixing the ribavirin with the chitosan to form sol gel; adding a preservative; then adjusting the pH value to 5.8-6.2 by using a pH adjusting agent; mixing uniformly; and sterilizing and packaging so as to finish the preparation. According to the invention, the water-soluble gel is adopted as a substrate to prepare the ribavirin nasal gel; the preparation process is simple; and the ribavirin slow release nasal gel remains in the nasal cavities for a long time and has a certain slow release effect, so that the biological utilization rate of the ribavirin slow release nasal gel is added, a good treatment function of the ribavirin slow release nasal gel is played, and low toxic and side effect is caused. The ribavirin slow release nasal gel used for treating cold has a relatively strong inhibition effect on the common infected influenza virus, and is convenient and comfortable to use.

Description

technical field [0001] The invention belongs to the field of medicine and relates to nasal drops, in particular to ribavirin nasal drops for treating colds and flu and a preparation method thereof. Background technique [0002] Ribavirin, also known as ribavirin or ribavirin, is a broad-spectrum antiviral drug. Ribavirin Nasal Drops has definite curative effect on preventing and treating nasal infection, and its clinical use in treating viral influenza has been included in the Chinese Pharmacopoeia. The preparation method of nasal drops is simple and the cost is low, but when administering the drug, the drug loss of nasal drops will cause individual differences, and due to the clearing function of nasal cilia, the retention time of the liquid in the nasal cavity is short, so to a certain extent Affect the absorption and efficacy of the drug. And nasal drops will inevitably stay in the pharynx in many processes, stimulate the pharyngeal mucosa, and symptoms such as xerostom...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/06A61K31/7056A61K47/36A61P11/02A61P31/12
Inventor 徐鸿博
Owner HUAZHONG UNIV OF SCI & TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products